Literature DB >> 8233525

Human brain measures of clinical pain: a review. I. Topographic mappings.

Andrew C N Chen1.   

Abstract

A comprehensive paper (Parts I and II) has been developed to review the cerebral measures employed in studying the brain neurophysiological activities of clinical pain. Part I focuses on the electro-, magnetic-physiological assessment of clinical pain, and Part II concerns the anatomico-, chemical-physiological assessment of clinical pain. In Part I, these measures include the qualitative inspection of the conventional electroencephalogram, quantitative assessment of brain electrical spectral activity through cortical power spectrum density and coherence analyses, and quantitative averaging of cortical electrical or magnetic activities using brain evoked potentials. The mapping and measurement of these electrical activities and magnetic fields are results of recent advent in computer technology and advanced algorithms. Promises and limitations of these topographic measures in understanding pain in the brain are stated. The next article (Part II) of this paper will review tomographic imaging of pain-related brain activities in regional cerebral flow, the scanning of gross and fine brain structures by computerized axial tomography or magnetic resonance imaging, and the imaging and measurement of brain metabolic changes, energy uptake, and receptor bindings through positron emission tomography or single-photon emission computerized tomography. Molecular chemical transformation by the nuclear magnetic resonance analysis of tissue changes and analgesic-receptor interactions will also be noted.

Entities:  

Mesh:

Year:  1993        PMID: 8233525     DOI: 10.1016/0304-3959(93)90200-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  16 in total

1.  A novel modelling and experimental technique to predict and measure tissue temperature during CO2 laser stimuli for human pain studies.

Authors:  Mohammed Hamed Al-Saadi; V Nadeau; M R Dickinson
Journal:  Lasers Med Sci       Date:  2006-05-04       Impact factor: 3.161

Review 2.  Cerebral mechanisms operating in the presence and absence of inflammatory pain.

Authors:  A K Jones; S W Derbyshire
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

3.  Effects of azapropazone on pain-related brain activity in human subjects.

Authors:  J Lötsch; P Mohammadian; T Hummel; S Florin; K Brune; G Geisslinger; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

Review 4.  Experimental human pain models in gastro-esophageal reflux disease and unexplained chest pain.

Authors:  Asbjørn Mohr Drewes; Lars Arendt-Nielsen; Peter Funch-Jensen; Hans Gregersen
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

5.  Short latency cerebral response evoked by painful electrical stimulation applied to the human sigmoid colon and to the convergent referred somatic pain area.

Authors:  Petra Rössel; Lars Arendt-Nielsen; David Niddam; Andrew C N Chen; Asbjørn M Drewes
Journal:  Exp Brain Res       Date:  2003-04-24       Impact factor: 1.972

6.  Brain and human pain: topographic EEG amplitude and coherence mapping.

Authors:  A C Chen; P Rappelsberger
Journal:  Brain Topogr       Date:  1994       Impact factor: 3.020

Review 7.  Higher cortical modulation of pain perception in the human brain: Psychological determinant.

Authors:  Andrew Cn Chen
Journal:  Neurosci Bull       Date:  2009-10       Impact factor: 5.203

8.  [Brain tumor and headache.].

Authors:  I Kiss; M Franz; M Kilian
Journal:  Schmerz       Date:  1994-09       Impact factor: 1.107

9.  Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects.

Authors:  J Lötsch; G Geisslinger; P Mohammadian; K Brune; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

Review 10.  Neuromodulatory treatments for chronic pain: efficacy and mechanisms.

Authors:  Mark P Jensen; Melissa A Day; Jordi Miró
Journal:  Nat Rev Neurol       Date:  2014-02-18       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.